Płukanie zatok roztworem Bedatyny lub wodorowęglanu sodu we wczesnym leczeniu Covid 2x skuteczniejsze, niż Paxlovid
A szprej z ksylitolem i pestkami z greifruta wysoce skuteczny w zapobieganiu infekcji.
2.5mL Bedatyny lub 2.5 mL wodorowęglanu sodu (proszku do pieczenia)
Rapid initiation of nasal saline irrigation to reduce severity in high-risk COVID+ outpatients
Patients randomly assigned to add 2.5 mL povidone-iodine 10% or 2.5 mL sodium bicarbonate to 240 mL of isotonic nasal irrigation twice daily for 14 days. Symptom resolution was more likely for those reporting twice daily irrigation (X2 = 8.728, P = .0031) regardless of additive.
Conclusion:
SARS-CoV-2+ participants initiating nasal irrigation were over 8 times less likely to be hospitalized than the national rate.
https://journals.sagepub.com/doi/10.1177/01455613221123737?utm_source=substack&utm_medium=email
https://articles.mercola.com/sites/articles/archive/2022/10/17/saline-nasal-irrigation-covid.aspx?ui=d90e7ee23f736e3fe79caa865ff2ed15a05fefdf54e3ba3681d683ddd0a14880&sd=20210522&cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20221017_HL2&cid=DM1267068&bid=1622475617
STORY AT-A-GLANCE
Rinsing your nasal passages with a saline solution within 24 hours of a COVID-19 diagnosis could reduce your chances of being hospitalized by 8.5-fold
Among people with COVID-19 who used nasal irrigation twice daily, 80% had zero or one mild symptom, compared to 42% of those who irrigated less often
Only 13% of those who used nasal irrigation still had symptoms at day 28, compared to nearly 50% of those in another study
Other research also supports the use of nasal irrigation as a “useful add-on to first-line interventions for COVID-19”
Nebulized hydrogen peroxide diluted with saline, with or without iodine, can also be safely used by most people for prevention of respiratory infections — and in cases of active infection
Rinsing your nasal passages with a saline solution within 24 hours of a COVID-19 diagnosis could reduce your chances of being hospitalized by 8.5-fold.1 Why hasn't your doctor told you about this? And why haven't public health agencies shared the good news with the public that they can significantly reduce their risk of severe COVID-19 with a simple nasal wash?
The practically free solution is just too inexpensive. Unlike Pfizer's Paxlovid, which was granted emergency use authorization to treat mild to moderate COVID-19 in December 20212 — and is slated to make the company $22 billion in profits in 20223 — there's little money to be made by promoting the ancient practice of nasal lavage.
Further, if its benefits are confirmed, widespread usage could have drastically altered the course of the pandemic, rendering the entire pandemic response completely unnecessary.4
Simple Way to Reduce Your Risk of COVID Hospitalization
Nasal irrigation, sometimes referred to as nasal lavage, is a relatively popular method for relieving cold symptoms, often via the use of a neti pot. The practice is an ancient technique with roots in the traditional Indian health care system, however.
Irrigating the nasal passages with saline is used in traditional yoga practice, where it's known as jala-neti.5 It involves the use of a saline solution in teapot-like device, used to flush out the nose and sinus cavities. After inserting the end of the pot in one side of your nose, the solution moves through your sinuses and out the other nostril. A bulb syringe or squeeze bottle can also be used.
In the U.S., nasal irrigation continues to be an adjunctive therapy for upper respiratory conditions and is currently prescribed after nasal and sinus surgeries.6 The featured study, which was published in the Ear, Nose & Throat journal in August 2022, involved 79 participants 55 and older who were diagnosed with COVID-19.7
They were randomly selected to use either one-half teaspoon of sodium bicarbonate (alkalinization) with an isotonic normal saline (0.9% saline) rinse twice a day for 14 days or to include 2.5 milliliters (roughly a half-teaspoon) of povidone-iodine (PVP-I) 10% solution (antimicrobial) for the same period. The researchers then followed up with each group 14 days after their final intervention.
Those who used nasal irrigation were more than 8.5 times less likely to be hospitalized compared to the national rate, the study found. A dose-response relationship was also found. Among those who irrigated twice daily, 80% had zero or one mild symptom, compared to 42% of those who irrigated less often.
Further, only 13% of those who used nasal irrigation still had symptoms at day 28, compared to nearly 50% of those in another study, who had continued symptoms for 21 days or more.8 According to the researchers:9
"Our results support that pressurized nasal irrigation reduces the likelihood of hospitalization in high-risk COVID-19 + outpatients, suggesting a safe and over the counter measure with potentially vital public health impact.
The reduction from 11 to 1.3% as of November 2021 would have corresponded in absolute terms to over 1,000,000 fewer older Americans requiring admission. If confirmed in other studies, the potential reduction in morbidity and mortality worldwide could be profound."
Senior study author Dr. Richard Schwartz noted, "We found an 8.5-fold reduction in hospitalizations and no fatalities compared to our controls. Both of those are pretty significant endpoints."10 In addition to the featured study, other research also supports the use of nasal irrigation as a "useful add-on to first-line interventions for COVID-19."11